Immunomodulatory agents and cell therapy for patients with type 1 diabetes.
- DOI
- 10.20945/2359-4292-2024-0233
- Published
- 2025-04-11
- Container
- Arch Endocrinol Metab
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.20945/2359-4292-2024-0233,
title = {Immunomodulatory agents and cell therapy for patients with type 1 diabetes.},
author = {Rodacki M and Silva KR and Araujo DB and Dantas JR and Ramos MEN and Zajdenverg L and Baptista LS.},
year = {2025},
journal = {Arch Endocrinol Metab},
doi = {10.20945/2359-4292-2024-0233},
url = {https://doi.org/10.20945/2359-4292-2024-0233}
}RIS
TY - JOUR TI - Immunomodulatory agents and cell therapy for patients with type 1 diabetes. AU - Rodacki M AU - Silva KR AU - Araujo DB AU - Dantas JR AU - Ramos MEN AU - Zajdenverg L AU - Baptista LS. PY - 2025 JO - Arch Endocrinol Metab DO - 10.20945/2359-4292-2024-0233 UR - https://doi.org/10.20945/2359-4292-2024-0233 ER -
APA
M, R., KR, S., DB, A., JR, D., MEN, R., L, Z., & LS., B. (2025). Immunomodulatory agents and cell therapy for patients with type 1 diabetes.. Arch Endocrinol Metab. https://doi.org/10.20945/2359-4292-2024-0233
Source records
- europe-pmc · retrieved 2026-09-26T00:57:06.185Z
- doaj · retrieved 2026-09-26T00:57:06.211Z